Medical City Dallas opened a new $6 million abdominal transplant clinic that brings together pancreas, liver, and kidney patients into the same unit. The clinic is part of a $23 million expansion of the hospital’s transplant program. The clinic and other expanded services include more than doubling the current footprint to 32,560 square feet and 23 new exam rooms and one procedure room. The new space includes an operating room is dedicated to liver, kidney, and pancreas transplants, and has a new ultrasound, a 10-bed intensive care unit dedicated to transplant patients. In 2022, the abdominal transplant program saw 5,000 patients and hosted more than 13,000 visits.
Great Place To Work and Fortune magazine recognized Texas Health Resources as one of the 2023 Best Workplaces for Women. This was the seventh time the nonprofit has been named to the list. It was named No. 56 out of 100 large companies, and was the only health system in North Texas on the list. Women hold over 71 percent of leadership roles throughout the system, including 51 percent of officer level positions. Survey responses from more than 600,000 women determined the honorees.
The venture capital and impact investing arm of the American Cancer Society, BirghtEdge LLC, received its largest donation of $5.25 million from Dallas-based Lyda Hill Philanthropies to form the ACS BrightEdge Texas Accelerator, a two-year pilot innovation acceleration program hub. The grant will fund translational research grants and early stage emerging oncology startup companies. Lack of early stage capital, talent development, and mentorship in the cancer space have long been problems, and the grant will provide funding and guidance to address those issues by creating a network of ACS-affiliated advisers and partners.
Dallas-based healthcare services firm IKS Health has acquired Aquity Solutions, a clinical documentation, medical coding, and revenue solutions company, for $200 million. IKS works to take the administrative and operational burden off of providers, and IKS founder and CEO Sachin Gupta says the acquisition will provide stability to providers in a deepening healthcare crisis. The combined company will operate as IKS Health and have annual revenues of $330 million with more than 14,000 employees serving over 150,000 clinicians.
Author
